Alignment Healthcare, Inc. (ALHC) vs Ocular Therapeutix, Inc. (OCUL)

A side-by-side comparison of Alignment Healthcare, Inc. and Ocular Therapeutix, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ALHC vs OCUL

growth of $100 · dividends reinvested · last 6y
ALHC -50.9% (-11.2%/yr)OCUL -61.0% (-14.5%/yr)ALHC compounded faster over this window
050100150Start $10020222023202420252026$49$39
ALHC OCUL

ALHC vs OCUL: by the numbers

  • •ALHC is the larger company ($1.72B vs $1.61B market cap).
  • •ALHC is profitable (0.89% net margin) while OCUL runs a net loss (-579.10%).
  • •ALHC grew revenue faster over the past five years (33.83% vs 10.03% CAGR).

Metrics side by side

Valuation

MetricALHCOCUL
P/E ratio44.56N/A
Forward P/E45.80N/A
P/S ratio0.3830.90
P/B ratio6.513.09
EV / EBITDA15.74N/A

Profitability

MetricALHCOCUL
Gross margin12.55%87.11%
Operating margin1.20%-521.04%
Net margin0.89%-579.10%
ROE15.35%-57.97%
ROIC9.23%-50.20%

Growth (annualized)

MetricALHCOCUL
Revenue CAGR (5Y)33.83%10.03%
Total return CAGR (5Y)-12.15%-5.73%

Frequently asked

Which has grown faster, ALHC or OCUL?
Over the past five years, ALHC grew revenue faster — ALHC at a 33.83% CAGR versus OCUL at 10.03%.
Is ALHC or OCUL more profitable?
ALHC runs the higher net margin — ALHC at 0.89% versus OCUL at -579.10%.
How have ALHC and OCUL total returns compared?
Over the past 5 years, ALHC delivered -12.15% and OCUL delivered -5.73% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.